A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of ...

The Chief Medical Officer and Director of Global Healthcare and Non-profits at Amazon Web Services, Dr Rowland Illing, has ...

Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer ...

When Izzy’s ‘Pops’, who had lived with Parkinson’s for more than a decade, lost his ability to write, she and her friend ...

CBS News Miami spoke to Jeff Lee, a devoted caregiver who has spent the last several years caring for his longtime partner, ...

For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...

THURSDAY, April 17, 2025 (HealthDay News) -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says.

Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 7, 2025 — A study ...